VIVS logo
VIVS NASDAQ US

VivoSim Labs, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Aug 2013
$1.69
▲ +$0.07 (+4.32%)
Vol 56K
3
Quality Score
fail
Mkt Cap
$4.7M
ROE
-28.9%
Margin
-1416.4%
D/E
0.00
Beta
1.23
52W
$1–$22

Wall Street Consensus

7 analysts · Dec 2021
0
Strong Buy
0
Buy
4
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

AKTX
Akari Therapeutics PLC
$9.4M
FBLG
Fibrobiologics Inc
$15.0M
REVB
Revelation Biosciences Inc
$4.7M
SILO
Silo Pharma Inc
$4.5M
SHPH
Shuttle Pharmaceuticals Holdings Inc
$2.9M
MTVA
MetaVia Inc
$19.4M
APVO
Aptevo Therapeutics Inc
$8.8M

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2024 $-2.57 $-2.29 +$0.28
Sep 2024 $-3.18 $-1.68 +$1.50
Jun 2024 $-4.04 $-2.76 +$1.28
Mar 2024 $-5.14 $-3.48 +$1.66

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -33.0% -46.9% -33.0% -33.0% -33.0% -28.9%
P/E (TTM) — — — — — —
Net Margin -7683.8% -1727.8% -1399.3% -1399.3% -1399.3% -1416.4%
Gross Margin 100.0% 96.5% 97.9% 97.9% 97.9% 98.6%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 4.52 3.25 4.52 4.52 4.52 3.10

Key Ratios

ROA (TTM)
-19.8%
P/S (TTM)
33.72
EPS (TTM)
$1.91
Rev Growth 3Y
-54.2%
52W High
$21.96
52W Low
$1.41
$1.41 52-Week Range $21.96

How does VIVS compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

VIVS AAPG ABEO ABOS ABP

VIVS valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
33.7
▲ 162% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
—
▼ 0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

VIVS profitability vs Biotechnology peers

ROE
-28.9%
▲ 57% above peers (-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-1416.4%
▼ 394% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
98.6%
▲ 25% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-19.8%
▲ 58% above peers (-46.7%)
vs Peers
vs Industry
Top tier

VIVS financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.1
▼ 30% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.2
▲ 27% above peers (1.0)
vs Peers
vs Industry
More volatile

VIVS fundamentals radar

VIVS Peer median Industry

VIVS profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

VIVS vs peers: key metrics

Latest News

No related news yet